Robotic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Therapy

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

First Affiliated Hospital of Nanjing Medical Unviersity, Nanjing, Jiangsu

Phase

Safety & dosing

Sponsor

The First Affiliated Hospital with Nanjing Medical University

Collaborators

Jiangsu Cancer Institute & Hospital, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Enrollment target

~40 participants

Started

November 2024

Primary completion

November 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 80 Years

Last updated July 2025